Bicara Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCAX and other ETFs, options, and stocks.About BCAX
Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor.
BCAX Key Statistics
Stock Snapshot
Bicara Therapeutics(BCAX) stock is priced at $16.74, giving the company a market capitalization of 917.05M. It carries a P/E multiple of -7.51.
On 2026-01-24, Bicara Therapeutics(BCAX) stock moved within a range of $16.59 to $17.93. With shares now at $16.74, the stock is trading +0.9% above its intraday low and -6.6% below the session's peak.
Trading volume for Bicara Therapeutics(BCAX) stock has reached 334.29K, versus its average volume of 458.17K.
Over the past 52 weeks, Bicara Therapeutics(BCAX) stock has traded between a high of $19.71 and a low of $7.80.
Over the past 52 weeks, Bicara Therapeutics(BCAX) stock has traded between a high of $19.71 and a low of $7.80.
Analyst ratings
82%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.